Candel Therapeutics, Inc.CADLNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+8.1%
5Y CAGR+24.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+8.1%/yr
Annual compound
5Y CAGR
+24.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $17.77M | +26.4% |
| 2024 | $14.06M | -2.5% |
| 2023 | $14.41M | +2.5% |
| 2022 | $14.06M | +24.9% |
| 2021 | $11.26M | +87.8% |
| 2020 | $5.99M | +134.6% |
| 2019 | $2.56M | - |